PrEP’ing in the 2020s

Empowering PCPs to Prevent HIV

Staying Vigilant for Immunocompromised Patients

PrEP for Teens and Young Adults

Are You Doing Your Part to Prevent HIV in Your Patients?

Understanding PrEP Needs in Women

HIV Prevention in OB/GYN Practice

Emerging Issues in HIV Management

Answers to Pharmacists’ Common Questions

New Opportunities for HIV Prevention in the Pharmacy Setting

Building HIV Pathways

Building Bridges to Reach People with HIV Toward the Goal of Re-engagement in Care

Putting Together Clues in HIV, CVD, T2D, and CKD

Escaping Management Mishaps

Top 10 COVID Queries

Answers to Your Questions About Managing High-Risk Patients

Building HIV Pathways

Building Bridges to Reach People With HIV Toward the Goal of Re-Engagement in Care

Hot Topics in Systemic Lupus Erythematosus

Overcoming Barriers to Optimize Patient Outcomes

Strengthening Your COVID-19 Management Technique

Exercising Best Practices for Hospitalized Patients

Staying the Course Through Critical Junctions in Care

What’s New in the Management of COVID-19

Incorporating New Data and Updated Guidelines Into Daily Practice

Answers to Everyday Practice Challenges in HIV Medicine

A Phone-a-Friend CME Series – Volume 2

What’s the Latest on COVID-19?

Optimizing HIV and HCV Treatment and Prevention Among People Experiencing Homelessness

A Call to Action

Monoclonal Antibodies for the Prevention and Treatment of COVID-19

PrEParing to End the Epidemic

Optimizing HIV Prevention in Primary Care

Long-Acting Injectable PrEP:

Bringing HIV Prevention to a New Level

BRIDGE PrEP

Building Bridges to Reach People who Inject Drugs with the Goal of Employing PrEP for HIV Prevention

Are You Up to Date on COVID-19 Diagnosis and Treatment Guidelines?

Test Your Mastery!

Pharmacy PrEP Education

A “How To” Series Spanning Policy to Practice

Buffing Up on New and Emerging ART

A Look at the Changing HIV Playing Field

Applying HIV Advances in Practice

What the Pharmacist Needs to Know

A Clinician’s Guide to HCV Treatment in the Primary Care Setting

Virologic Failure in HIV

An Updated Clinician’s Guide to Assessment and Management

Flexing Your HIV Prevention Muscles and Mastering PrEP Implementation

Monoclonal Antibodies for COVID-19

New Avenues to Pre-Exposure Prophylaxis

Monoclonal Antibodies for COVID-19

An Update on Best Practices

Clinical Updates in COVID-19

Recent Developments in Anti-SARS-CoV-2 Monoclonal Antibodies for Treatment

Test Your HIV Management Skills Across the Spectrum of Care

Treating Hepatitis C in the Primary Care Setting

Establishing Clinical Readiness Through Mentored Learning

Minimizing Patient Risks From COVID-19

An Update on Monoclonal Antibody Therapies

Clinical Issues in COVID-19

Debates and Discussions about Monoclonal Antibody Therapies

Hot Topics in HCV

A Multidisciplinary Online Mini-Curriculum

Answers to Everyday Practice Challenges in HIV Medicine

Honing Clinical Skills in HIV Treatment

Considering the Patient, the Provider, and the Science

Treating Hepatitis C in the Primary Care Setting

A Critical Step Toward HCV Elimination

Expanding HIV Prevention in Colorado—and Nationwide

A PEP/PrEP Training Guide for Pharmacists

A Critical Appraisal of Non-Invasive Technologies in NASH

Informing the Future of NASH Diagnosis and Assessment

Challenges and Opportunities in HIV

Practical Solutions Across the Spectrum of Care

Case Challenges in HIV Medicine

Benefits, Barriers, & Best Practices in an Advancing Field

BRIDGE HCV

Building Bridges to Reach People Who Inject Drugs With the Goal to Eliminate HCV

Trending Clinical Issues Influencing HIV Practice Today

HIV Updates for Pharmacy Practice

Maximizing Your Role to Impact Patient Outcomes

Evolving Models of HIV Care (Volume 3)

The Rapid ART Standard of Care: From Evidence to Healthcare Equity

The Changing Landscape of HIV Prevention

What the Pharmacist Needs to Know about PrEP

Stepping Up to the Challenge

The PCP’s Role in HCV Elimination

HIV Prevention in Primary Care Practice

A PrEP Primer

Optimizing Sexual Health and Decreasing HIV Risk